Concerns grow in the US over contamination of drugs made in Indian pharma facilities
Updated : August 29, 2019 04:30 PM IST
More than 90 percent of the drugs prescribed in the US are generics, and over time, most companies have moved their manufacturing overseas — especially to India and China — to take advantage of cheaper labour and materials.
But concerns over of a raft of allergic reactions, side effects and even deaths in the US linked to contaminated drugs made in overseas facilities have grown significantly in recent times.
US drugmakers have issued more than 50 recalls since last July linked to low levels of a probable cancer-causing chemical found in generic drugs taken by millions of Americans.
Have you signed up for Primo, our daily newsletter?
It has all the stories and data on the market, business, economy and tech that you need to know.
THANK YOU! You made our day. See you every morning
YOUR EMAIL IS ON ITS WAY. Check your inbox for future updates.
To keep watching CNBC-TV18, India's No. 1 English Business News Channel, call your Cable or DTH Operator and subscribe now for just Rs. 4 per month. You can also subscribe to CNBC-TV18 Prime HD for Re 1/- per month.Find out more